Table 3.

Network meta‐analysis comparisons

	Placebo	ACEIs	CCBs	Diuretics	Beta‐blockers	ARBs
Placebo	1	2.04(1.18,3.57)	0.88(0.63,1.20)	0.73(0.40,1.09)	0.73(0.48,1.10)	2.70(1.92,3.84)
ACEIs	0.49(0.28,0.85)	1	0.90(0.66,1.20)	0.74(0.56,0.98)	0.75(0.50,1.10)	1.20(0.81,1.90)
CCBs	1.10(0.85,1.60)	1.10(0.81,1.50)	1	0.83(0.61,1.10)	0.83(0.55,1.20)	1.30(0.94,2.00)
Diuretics	1.40(0.91,2.50)	1.30(1.00,1.80)	1.20(0.91,1.60)	1	1.00(0.68,1.50)	1.60(1.10,2.50)
Beta‐blockers	1.40(0.93,2.10)	1.30(0.90,2.00)	1.20(0.81,1.80)	0.99(0.68,1.50)	1	1.60(1.10,2.70)
ARBs	0.37(0.26,0.52)	0.82(0.53,1.20)	0.74(0.50,1.10)	0.61(0.40,0.89)	0.62(0.38,0.96)	1

Abbreviations: ACEIs: angiotensin‐converting enzyme inhibitors; ARBs: angiotensin II receptor blockers; CCBs: calcium channel blockers.